Learn how to talk about mental health medications without shame. Discover practical strategies to reduce stigma, improve communication, and normalize treatment using real-world evidence and expert-backed approaches.
Hypertensive retinopathy is eye damage caused by high blood pressure, often without symptoms until vision is at risk. Learn how it progresses, how to detect it early, and what you can do to protect your sight.
Learn how dissolution profiles are used to prove generic drugs work like brand-name versions. Understand the f2 factor, regulatory standards, and why this test saves time and money without compromising safety.
Hidradenitis suppurativa causes painful, recurring nodules and abscesses. Biologic therapies like adalimumab, secukinumab, and bimekizumab target inflammation at the source, offering real relief for moderate-to-severe cases. Learn how they work, how they compare, and what to expect.
Learn how large print and accessible prescription labels help people with low vision take medications safely. Discover what standards apply, which pharmacies offer them, and how to get them - no doctor’s note needed.
Hospital pharmacies are bearing the brunt of a growing crisis: sterile injectable drug shortages. With 226 active shortages in mid-2025, critical medications like anesthetics and chemotherapy drugs are vanishing - forcing staff to make impossible choices and delay life-saving treatments.
Deep Brain Stimulation (DBS) can dramatically reduce Parkinson’s motor symptoms for eligible patients. Learn who benefits most, how STN and GPi targets differ, what the evaluation process involves, and what to expect before and after surgery.
Grapefruit juice can dangerously increase simvastatin levels in the blood, raising the risk of muscle damage and kidney failure. Learn how much is unsafe, which statins are safer, and what symptoms to watch for.
Rhabdomyolysis from medication interactions is a silent threat - often missed until kidneys fail. Statins, antibiotics, and common combos can trigger muscle breakdown. Know the signs, ask the right questions, and protect yourself.
The first generic drug to hit the market after a patent expires captures up to 80% of sales during its 180-day exclusivity window-and often keeps 30-40% long after. Here’s why being first matters more than price.